Cohen Capital Management’s Moderna MRNA Stock Holding History

Cohen Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$243K	Buy	+3,470	New	+$180K	0.03%	145
2025 Q4	–	Sell	-9,072	Closed	-$234K	–	154
2025 Q3	$234K	Sell	9,072 -1,273	-12%	-$35.5K	0.04%	139
2025 Q2	$285K	Sell	10,345 -593	-5%	-$15.6K	0.05%	139
2025 Q1	$310K	Hold	10,938	–	–	0.05%	130
2024 Q4	$455K	Buy	10,938 +1,984	+22%	+$94.8K	0.08%	118
2024 Q3	$598K	Sell	8,954 -288	-3%	-$26.4K	0.1%	114
2024 Q2	$1.1M	Hold	9,242	–	–	0.19%	88
2024 Q1	$985K	Buy	9,242 +242	+3%	+$24.4K	0.17%	89
2023 Q4	$895K	Hold	9,000	–	–	0.17%	88
2023 Q3	$930K	Hold	9,000	–	–	0.19%	88
2023 Q2	$1.09M	Hold	9,000	–	–	0.21%	84
2023 Q1	$1.38M	Hold	9,000	–	–	0.28%	77
2022 Q4	$1.62M	Hold	9,000	–	–	0.33%	72
2022 Q3	$1.06M	Hold	9,000	–	–	0.23%	85
2022 Q2	$1.29M	Hold	9,000	–	–	0.26%	87
2022 Q1	$1.55M	Buy	+9,000	New	+$1.52M	0.27%	87

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Cohen Capital Management's MRNA Position: Q2 2026 in Review

Cohen Capital Management opened a new position in Moderna (MRNA) in Q2 2026: 3,470 shares worth $243K. The stake represents 0.03% of the portfolio and ranks #145 among its holdings. This is a return to the name: Cohen Capital Management previously reported a position in MRNA as recently as Q3 2025.

Cohen Capital Management first reported a position in MRNA in Q1 2022 and has held it in 16 quarters since. The position peaked at $1.62M in Q4 2022. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Cohen Capital Management held 3,470 shares of Moderna worth $243K as of Q2 2026.
Moderna was a new Cohen Capital Management position in Q2 2026.
Moderna made up 0.03% of Cohen Capital Management's portfolio in Q2 2026, its #145 holding.
Cohen Capital Management first reported a position in Moderna in Q1 2022 and has held it in 16 quarters since.
Cohen Capital Management's Moderna position peaked at $1.62M in Q4 2022.
783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Cohen Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.